← All companies

VCEL

Vericel Corporation

VCEL Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$45.66

-0.40 -0.86%

Key statistics

from XBRL data in SEC filings

Market cap

$2.34B

Revenue (TTM)

$306M

Net income (TTM)

$24.2M

EPS (TTM)

$0.48

P/E ratio

95.1

Dividend yield

—

Free cash flow

$24.7M

Cash

$125M

Total assets

$503M

Gross margin

74.6%

52-week range

$28.95 – $49.32

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Jul 30, 2026 8-K Results of operations (earnings release) Jul 30, 2026 8-K Amended charter or bylaws May 18, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Shareholder vote results May 1, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-06-30 Jul 31, 2025 8-K Results of operations (earnings release) Jul 31, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Director or officer change; Shareholder vote results May 2, 2025 8-K Regulation FD disclosure Apr 14, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 14, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Other events Aug 26, 2024 8-K Other events Aug 15, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release) Aug 1, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 8-K Shareholder vote results May 3, 2024 10-K Fiscal year ended 2023-12-31 Feb 29, 2024 8-K Results of operations (earnings release) Feb 29, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Jan 9, 2024 10-Q Quarter ended 2023-09-30 Nov 8, 2023 8-K Results of operations (earnings release) Nov 8, 2023 8-K Other events Sep 20, 2023 10-Q Quarter ended 2023-06-30 Aug 2, 2023 8-K Results of operations (earnings release) Aug 2, 2023 10-Q Quarter ended 2023-03-31 May 10, 2023 8-K Results of operations (earnings release) May 10, 2023 8-K Director or officer change; Shareholder vote results May 5, 2023